Retraction

Ion channel blocking profile of compounds with reported torsadogenic effects: what can be learned?

Retraction Details

Retraction Reason:

Duplication of Data

Nature of Retraction:

Retraction

Additional Notes:

affiliations from duplicated article.

Citations (3)

3
Total Citations
2
Post-Retraction
(66.7%)
0
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
1 Within 30 days
1 Within 1 year
1 After 2+ years
4615 Days since retraction (latest)
Paper citing Ion channel blocking profile of compounds with rep...
Unknown Authors
Unknown Journal
Published: Unknown
Insight in article retractions in <i>British Journal of Pharmacology</i> between the years 2000–2023. Implications for reducing fraud‐containing articles
Marcel A. G. van der Heyden
British Journal of Pharmacology
Published: Jul 2024
2 citations
4615 days after retraction
Paper citing Ion channel blocking profile of compounds with rep...
Unknown Authors
Unknown Journal
Published: Dec 2011
16 days after retraction
Quick Stats
Total Citations: 3
Years Since Retraction: 14.0 years
Open Access: Yes
Last Checked: Never
Related Papers
Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2, ligands…
British Journal of Pharmacology • 99 citations
Cloricromene, a Coumarine Derivative, Protects Against Coll…
British Journal of Pharmacology • 72 citations
Pyrrolidine Dithiocarbamate Attenuates the Development of A…
British Journal of Pharmacology • 213 citations
Pioglitazone Improves Lipid and Insulin Levels in Overweigh…
British Journal of Pharmacology • 106 citations
Diosmetin induces apoptosis and enhances the chemotherapeut…
British Journal of Pharmacology • 73 citations